Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Awakn Life Sciences

EXCLUSIVE: New Partnership Brings Leading Psychedelic Protocol For Alcoholism Treatment To NYC

NYC-based clinics brand Nushama has partnered with Awakn Life Sciences (OTCQB: AWKNF), a clinical-stage psychedelics biotech company to bring

Iter Closes Last Funding Round Of Psychedelics Pool, Higher Capital Market Investment Than Expected

Iter Closes Last Funding Round Of Psychedelics Pool, Higher Capital Market Investment Than Expected

Psychedelics VC fund Iter Investments has recently closed its last round of Fund I with over $20 million committed, a successful outcome considering the targeted raise in their first fund launch in April 2021, and an indication of investor interest in the psychedelics market.

Awakn's Study On Psychedelics For Treating Addiction Shows Promise, Will Undertake Broader Research

Awakn's Study On Psychedelics For Treating Addiction Shows Promise, Will Undertake Broader Research

Awakn Life Sciences (OTCQB: AWKNF) has announced the successful completion of the first ketamine study for a varied set of behavioral addictions.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Core One Labs Begins Trading On OTCQB

Under the CLABF symbol, psychedelics-oriented company Core One Labs (OTCQB:CLABF) started trading on the OTCQB Venture Market. The company’s CEO, Joel Shacker, commented: “Upgrading to the OTCQB is a timely and important milestone for Core One, as it will not only lead to increased corporate visibility in the US marketplace,…

Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!

It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector.

Stifel Initiates Coverage On Awakn Life Sciences With A Speculative Buy, $8 Target Price Target

Awakn Life Sciences (OTC: AWKNF) is in the news after a respected analyst has upgraded the stock. Awakn is a publicly traded company which trades on the over-the-counter market with the symbol of

Top 5 Most Influential Psychedelic Studies

This article was originally published on Psychedelic Spotlight and appears here with permission. While psychedelic studies now number in the thousands since Western research began in the 1950s, we unpack five of the most important in recent years as psychedelics are on the cusp of becoming mainstream medicines. When it…

inkl

Read news from The Economist, FT, and more,
with one subscription

Awakn Life Sciences Seeks To Treat Addictions: Gambling, Binge Eating And Compulsive Sexual Behavior

Awakn Life Sciences Seeks To Treat Addictions: Gambling, Binge Eating And Compulsive Sexual Behavior

Awakn Life Sciences (OTC: AWKNF) is not only going after alcoholism but also binge eating disorder, compulsive sexual behavior and even Internet gaming disorder.

As Australia legalises MDMA and psilocybin for medical use, we go inside one London psychedelics clinic

As Australia legalises MDMA and psilocybin for medical use, we go inside one London psychedelics clinic

Psychedelics are being touted as a cure for depression, addiction and PTSD — but will this new industry live up to the hype? As the Australian government announces that it will legalise MDMA and magic mushrooms for medical use, Alexandra Jones visits London’s first clinic to find out whether the…

Evening Standard

Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today

Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today

GAINERS: Awakn Life Sciences (OTC:AWKNF) shares closed up 3.51% at $1.62

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

University of Exeter

Compass Pathways

Psychedelic Spotlight

Awakn Life Sciences

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

397,269 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play